The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2024

Filed:

Apr. 15, 2022
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Gene M. Dubowchik, Middlefield, CT (US);

Olafur S. Gudmundsson, West Windsor, NJ (US);

Xiaojun Han, Cheshire, CT (US);

R. Michael Lawrence, Yardley, PA (US);

Dasa Lipovsek, Pepperell, MA (US);

Cort S. Madsen, West Windsor, NJ (US);

Claudio Mapelli, Linden, NJ (US);

Paul E. Morin, Pennington, NJ (US);

Michael C. Myers, Newtown, PA (US);

Assignee:

BRISTOL-MYERS SQUIBB COMPANY, Princeton, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/22 (2006.01); A61K 38/18 (2006.01); C07K 1/107 (2006.01); C07K 14/64 (2006.01); A61K 38/00 (2006.01); A61K 45/06 (2006.01); A61K 47/64 (2017.01); A61P 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/18 (2013.01); A61K 38/2221 (2013.01); C07K 1/1077 (2013.01); C07K 14/64 (2013.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01); A61K 47/64 (2017.08); A61P 9/00 (2018.01);
Abstract

The present disclosure generally relates to modified relaxin polypeptides, such as modified human relaxin 2 polypeptides, comprising a non-naturally encoded amino acid which is linked to a pharmacokinetic enhancer, and therapeutic uses of such polypeptides, such as for the treatment of cardiovascular conditions (such as heart failure) and/or conditions relating to fibrosis.


Find Patent Forward Citations

Loading…